Search Results

Abstract

OBJETIVO: Verificar a pressão intra-ocular (Po) em indivíduos usuários de análogos de prostaglandina, prostamida ou beta-bloqueador em portadores de glaucoma primário de ângulo aberto ou hipertensão ocular após leitura, exercício e exercício sob leitura. MÉTODOS: Quarenta indivíduos (79 olhos), subdivididos em 5 grupos: G1 (portadores de hipertensão arterial e glaucoma ou hipertensão ocular usando análogos de prostaglandinas ou prostamidas); G2 (portadores de hipertensão arterial e glaucoma ou hipertensão ocular usando beta-bloqueador); G3 (indivíduos sem hipertensão arterial e portadores de glaucoma ou hipertensão ocular em uso de análogos de prostaglandinas ou prostamidas); G4 (indivíduos sem hipertensão arterial e portadores de glaucoma ou hipertensão ocular em uso de beta-bloqueador) e G5 (indivíduos sem hipertensão arterial e sem glaucoma ou hipertensão ocular), tiveram a pressão intra-ocular verificada antes e após realizarem leitura, exercício e exercício sob leitura. Cada teste foi realizado em dia distinto e sempre no período vespertino. RESULTADOS: Não houve diferença estatisticamente significante na média da pressão intra-ocular inicial e final nos diferentes grupos do estudo quando submetidos à leitura, exercício e exercício sob leitura. CONCLUSÃO: Ler e fazer exercícios individualmente ou concomitantemente, não representa fator de agravo da pressão intra-ocular em portadores de glaucoma primário de ângulo aberto ou hipertensão ocular em usuários de análogos de prostaglandinas ou prostamidas ou beta-bloqueador.

Keywords: Glaucoma de ângulo aberto; Pressão intra-ocular; Leitura; Exercício; Hipertensão ocular; Prostaglandinas; Tonometria ocular

Abstract

PURPOSE: This study aimed to compare the safety and effectiveness of intraocular pressure reduction between micropulse transscleral cyclophotocoagulation and “slow cook” transscleral cyclophotocoagulation in patients with refractory primary open-angle glaucoma.
METHODS: We included patients with primary open angle glaucoma with at least 12 months of follow-up. We collected and analyzed data on the preoperative characteristics and postoperative outcomes. The primary outcomes were a reduction of ≥20% of the baseline value (criterion A) and/or intraocular pressure between 6 and 21 mmHg (criterion B).
RESULTS: We included 128 eyes with primary open-angle glaucoma. The preoperative mean intraocular pressure was 25.53 ± 6.40 and 35.02 ± 12.57 mmHg in the micropulse- and “slow cook” transscleral cyclophotocoagulation groups, respectively (p<0.001). The mean intraocular pressure was reduced significantly to 14.33 ± 3.40 and 15.37 ± 5.85 mmHg in the micropulse- and “slow cook” transscleral cyclophotocoagulation groups at the last follow-up, respectively (p=0.110). The mean intraocular pressure reduction at 12 months was 11.20 ± 11.46 and 19.65 ± 13.22 mmHg in the micropulse- and “slow cook” transscleral cyclophotocoagulation groups, respectively (p<0.001). The median preoperative logMAR visual acuity was 0.52 ± 0.69 and 1.75 ± 1.04 in the micropulse- and “slow cook” transscleral cyclophotocoagulation groups, respectively (p<0.001). The mean visual acuity variation was -0.10 ± 0.35 and -0.074 ± 0.16 in the micropulse- and “slow cook” transscleral cyclophotocoagulation, respectively (p=0.510). Preoperatively, the mean eye drops were 3.44 ± 1.38 and 2.89 ± 0.68 drugs in the micropulse- and “slow cook” transscleral cyclophotocoagulation groups, respectively (p=0.017), but those were 2.06 ± 1.42 and 1.02 ± 1.46 at the end of the study in the slow cook” and micropulse transscleral cyclophotocoagulation groups, respectively (p<0.001). The success of criterion A was not significant between both groups. Compared with 11 eyes (17.74%) in the slow cook” transscleral cyclophotocoagulation group, 19 eyes (28.78%) in the micropulse transscleral cyclophotocoagulation group showed complete success (p=0.171). For criterion B, 28 (42.42%) and 2 eyes (3.22%) showed complete success after micropulse- and slow cook” transscleral cyclophotocoagulation, respectively (p<0.001).
CONCLUSION: Both techniques reduced intraocular pressure effectively.

Keywords: Sclera/surgery; Glaucoma, open-angle/surgery; Ciliary body/surgery; Intraocular pressure; Laser coagulation/methods; Lasers, semiconductor; Comparative study; Effectiveness

Abstract

Glaucoma is a progressive optic neuropathy that can cause irreversible blindness, though it rarely affects women of reproductive age. Its management during pregnancy and lactation is particularly challenging because of the potential impact of intraocular pressure fluctuations on disease progression and the risks of treatment to both the mother and fetus. Physiological changes in pregnancy, such as decreased intraocular pressure and hormonal alterations, may influence disease activity but do not guarantee disease stability. Preconception counseling plays a key role in mitigating risks and tailoring treatment strategies. Many glaucoma medications carry teratogenic risks, with brimonidine being the only US Food and Drug Administration Category B drug. Surgical interventions – including laser trabeculoplasty and minimally invasive glaucoma surgeries – offer alternative options but require careful timing and consideration of fetal safety. Multidisciplinary collaboration is essential to optimize maternal and neonatal outcomes. This review summarizes evidence-based approaches for glaucoma management during pregnancy and lactation, highlighting clinical considerations, therapeutic strategies, and patient-centered care.

Keywords: Pregnancy complications; Glaucoma; Lactation; Parturition; Intraocular pressure